IHI vs TSM Stock Comparison
TSM currently leads IHI in this stock comparison, with AIQ scores of 66 vs 57. The clearest difference is quality, while IHI has the stronger momentum profile.
What is the main difference between IHI and TSM?
TSM leads the current stock comparison as Taiwan Semiconductor Manufacturing Company Limited, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
iShares U.S. Medical Devices ETF vs Taiwan Semiconductor Manufacturing Company Limited
TSM leads
TSM leads by 9 AIQ points, primarily on Quality and Value, but the lead has narrowed from 27 points over 30 sessions.
Fragile: 2 of 4 evidence groups support TSM, its lead is narrowing, and its current signal state is conflicted.
iShares U.S. Medical Devices ETF
Taiwan Semiconductor Manufacturing Company Limited
The Algovestiq AIQ Score currently favors TSM over IHI, 66 versus 57 as of Oct 31, 2026. TSM's advantage is driven primarily by stronger quality and value, while IHI holds the stronger momentum profile. TSM also shows the weaker technical structure relative to its 50-day moving average. 2 of 4 covered evidence groups favor TSM today, and the comparison is rated Fragile on stability: only 2 of 4 covered evidence groups agree. TSM lead: Weakening — the AIQ differential moved from 27 to 9 points over 30 sessions.
Compare iShares U.S. Medical Devices ETF and Taiwan Semiconductor Manufacturing Company Limited across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare IHI and TSM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality59 vs 98TSM +39
- Momentum79 vs 52IHI +27
- Value31 vs 45TSM +14
- Risk Resilience70 vs 65IHI +5
2 of 4 evidence groups favor TSM. TSM’s edge is concentrated in quality and value; IHI keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Risk Resilience +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 4 active signals are unchanged.
Largest factor move: Momentum +10
No signal started or stopped since the prior session; its 3 active signals are unchanged.
TSM's lead widened by 3 AIQ points in the latest session.
Deeper signal detail for each name lives on its own signals page — IHI and TSM both carry a full feed there.
The central trade-off
TSM (Taiwan Semiconductor Manufacturing Company Limited): the stronger current systematic profile, led by quality and value.
IHI (iShares U.S. Medical Devices ETF): the counter-case, on momentum, risk resilience.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
TSMTSM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
EvenGrowth figures are not covered for both names.
Value
TSMTSM on the peer-relative Value factor, by 14 points.
Momentum
IHIIHI on the Momentum factor, by 27 points.
Lower downside
IHIIHI on Risk Resilience, by 5 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | IHI | TSM | Note |
|---|---|---|---|
| Implied upside to target | — | +45% | Level |
| Target dispersion | — | +34% | Lower is tighter analyst agreement |
| Consensus | — | Buy | Context, not a primary driver |
| Analysts covering | — | 7 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
2 of 4 covered evidence groups favor TSM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | TSM | 57 vs 66 |
| Fundamentals | Not covered | Not covered |
| Valuation | TSM | Value 31 vs 45 |
| Technicals | Even | Price vs 50-day 2.9% vs -6.6%; vs 200-day 1.9% vs 10.1% |
| Risk Resilience | IHI | Risk Resilience 70 vs 65 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of IHI and TSM and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 9 points.
- Only 2 of 4 covered evidence groups agree. (argues the conclusion is provisional)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The lead has swung materially session to session. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TSM.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28TSM lead: Weakening — the AIQ differential moved from 27 to 9 points over 30 sessions.
- Today
- TSM +9
- 57 vs 66
- 7 sessions ago
- Level
- 57 vs 57
- 30 sessions ago
- TSM +27
- 47 vs 74
- 90 sessions ago
- TSM +12
- 50 vs 62
The lead changed hands once in this window, most recently on Oct 22 when IHI moved ahead of TSM.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
1 bullish / 2 bearish / 1 neutral, conflicted
Only IHI
- Bollinger Band Squeeze — neutral, volatility, short horizon
- Death Cross Active — bearish, trend, long horizon (1.06%)
- RSI Overbought — bearish, momentum, short horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
2 bullish / 1 bearish, conflicted
Only TSM
- Golden Cross Active — bullish, trend, long horizon (8.88%)
- Uptrend Structure Active — bullish, trend, long horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
TSM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.98%, AIQ 0 points).
Price is down while the AIQ Score moved up 3 points over the same session — price and model disagree (price -5.95%, AIQ +3 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1IHI closes the Quality gap — currently 39 points behind, the largest single contributor to TSM's edge.
- 2IHI's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3TSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
- 4The narrowing continues — the lead has already given back 18 points over 30 sessions, and a further 9-point move would eliminate TSM's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | IHI | TSM |
|---|---|---|
| Revenue growth (YoY) | — | 17.6% |
| EPS growth (YoY) | — | 8% |
| Gross margin | — | 65.8% |
| Operating margin | — | 57.9% |
| Return on equity (TTM) | — | 41.2% |
| Debt to equity | — | 0.14 |
Performance
TSM leads 4 of 6 windows| Metric | IHI | TSM |
|---|---|---|
| 1 week (5 sessions) | 2.3% | 1.8% |
| 1 month (20 sessions) | 6.8% | -3.7% |
| 3 months (63 sessions) | 3.6% | 9% |
| 6 months (126 sessions) | 4.5% | 11.6% |
| Year to date | -12.1% | 44.6% |
| 1 year (252 sessions) | -11.7% | 49% |
Technicals
Split| Metric | IHI | TSM |
|---|---|---|
| RSI (14) | 75.3 | 41.8 |
| ADX (14) | 24.8 | 19.9 |
| Price vs 50-day | 2.9% | -6.6% |
| Price vs 200-day | 1.9% | 10.1% |
| Volatility (1M, annualized) | 19.7% | 35.7% |
Risk
IHI is the more resilient| Metric | IHI | TSM |
|---|---|---|
| Beta | 0.4 | 2.14 |
| Sharpe ratio | -0.7 | 1.06 |
| Sortino ratio | -1.11 | 1.68 |
| Max drawdown | -26.2% | -21.6% |
| Current drawdown | -15.3% | -9.5% |
| Annualized volatility | 20.5% | 39.2% |
| Value at risk (95%) | -2.1% | -4.1% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, IHI or TSM?
On the Algovestiq AIQ Score, TSM is the stronger of the two as of Oct 31, 2026, scoring 66 against IHI's 57. The edge comes from quality and value. IHI is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is IHI or TSM the better buy right now?
TSM carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Fragile — 2 of 4 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 2 of 4 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor TSM over IHI?
The composite weights Quality, Value, Momentum and Risk Resilience. TSM leads Quality by 39 points; IHI leads Momentum by 27 points; TSM leads Value by 14 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, IHI or TSM?
Analyst price targets imply not covered upside for IHI and +45% for TSM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, IHI or TSM?
TSM is the better-valued of the two on the peer-relative Value factor. TSM on the peer-relative Value factor, by 14 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, IHI or TSM?
Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, IHI or TSM?
IHI on the Momentum factor, by 27 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, IHI or TSM?
IHI is the more resilient of the two, so the other name carries the higher downside risk. IHI on Risk Resilience, by 5 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is IHI more profitable than TSM?
Margin data is not comparable for both names in the current snapshot.
Is TSM's lead over IHI getting stronger or weaker?
TSM lead: Weakening — the AIQ differential moved from 27 to 9 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has changed hands once in that window, most recently on 2026-10-22, when IHI moved ahead of TSM.
What would change the IHI vs TSM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: IHI closes the Quality gap — currently 39 points behind, the largest single contributor to TSM's edge; IHI's Death Cross Active resolves — a bearish trend rule currently active against it; TSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 18 points over 30 sessions, and a further 9-point move would eliminate TSM's advantage entirely.
What do the current signals say about IHI and TSM?
IHI: 1 bullish / 2 bearish / 1 neutral, conflicted. TSM: 2 bullish / 1 bearish, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on IHI is Death Cross Active (bearish, long horizon). On TSM it is Golden Cross Active (bullish, long horizon).
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.